HOME >> BIOLOGY >> NEWS
UCSF set to transform itself into engine of translational research

Signaling a watershed moment in the evolution of UCSF, the National Insitutes of Health today announced that the University has received funding for a major new venture designed to accelerate the pace at which scientific discovery is translated into patient care.

The highly competitive funding mechanism, known as the Clinical and Translational Science Award, is being issued under the "NIH Roadmap," a strategic plan unveiled by NIH Director Elias A. Zerhouni, MD, in 2002 to drive the future of biomedical research.

Universities were encouraged to develop proposals to establish departments, centers or institutes, funded over five years, that would support innovative and far-reaching approaches for carrying out translational and clinical science. Seven universities, including UCSF, received funding for a full institute.

The UCSF Institute will be supported with more than $100 million over a period of five years.

The NIH funding mechanisms will support a nationwide consortium of departments, centers and institutes, beginning with 12 academic medical centers. When fully implemented in 2012, approximately 60 will be linked in the common effort.

"The development of this consortium represents the first systematic change in our approach to clinical research in 50 years," said Zerhouni. "These sites will serve as discovery engines that will improve medical care by applying new scientific advances to real world practice."

The UCSF Clinical and Translational Science Institute will extend across all four schools Dentistry, Medicine, Nursing, Pharmacy and its graduate division. It is designed to create an enterprise that promotes research and education in translational and clinical science at UCSF and its affiliated institutions, including the J. David Gladstone Institutes. The enterprise also will include Children's Hospital Oakland Research Institute, the Blood Systems Research Institute of San Francisco, the Kaiser Permanent Health System,
'"/>

Contact: Jennifer O'Brien
jobrien@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
3-Oct-2006


Page: 1 2 3 4 5

Related biology news :

1. New science of metagenomics will transform modern microbiology
2. Carnegie Mellon scientists use green approach to transform plastics manufacturing
3. NIH launches national consortium to transform clinical research
4. Science researchers genetically transform immune cells into tumor fighters
5. Completed genome set to transform the cow
6. UCLA researchers transform stem cells found in human fat into smooth muscle cells
7. Microbes transform safest PBDEs into more harmful compounds
8. Supercomputers to transform science
9. Gene needed for butterfly transformation also key for insects like grasshoppers
10. Amazonian terra preta can transform poor soil into fertile
11. Carnegie Mellon U. transforms DNA microarrays with standard Internet communications tool

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: UCSF set transform itself into engine translational research

(Date:2/5/2015)... 28, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... Global Online CEO Conference on January 29 th ... Pereira , CEO of NXT-ID will present and host ... Wocket smart wallet and its full suite of biometric ...
(Date:2/5/2015)... , Jan. 30, 2015  It is gratifying ... power and potential for genomic science as a means ... disease prevention and treatment.  I was honored to participate ... government-funded precision medicine program. Since the ... science of genomics—from the first sequenced genome of a ...
(Date:1/22/2015)... and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced the ... report to their offering. , The ... individual is who she/he is claiming to be, and for ... unique physical characteristics, such as fingerprint, hand or palm print, ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
(Date:3/3/2015)... Experts and industry insiders from around the ... Alltech REBELation exploring innovation, inspiration and world-changing ideas in ... 31st year, Alltech’s annual international conference traditionally draws more ... to join the REBELation at an extra discount registration ... at which point the standard early registration rate will ...
(Date:3/3/2015)... 2015 /CNW/- SQI Diagnostics Inc. (TSX:V: SQD), a life sciences ... products for advanced microarray diagnostics, today announced it ... its Management team. In his capacity as CFO ... from a development stage to a commercially successful ... Company,s capital market strategy and to secure funding ...
(Date:3/3/2015)... 3, 2015  Regenicin, Inc. (OTC Bulletin Board: ... development of and commercialization of regenerative cell therapies to ... today that it has received the final payment to ... Inc. (OTC Bulletin Board: AMBS ). ... the final payments due to Regenicin in the amount ...
(Date:3/3/2015)... ROCKVILLE, Md. , March 3, 2015  RegeneRx ... an editorial in the scientific journal, Expert Opinion ... and his colleague, Dr. Zhenggang Zhang , at ... reported that Thymosin beta 4 (TB4) has ... (PNS) remodeling 24 hours or more post-injury, leading to ...
Breaking Biology Technology:World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 3World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 4SQI Diagnostics Appoints Chief Financial Officer 2SQI Diagnostics Appoints Chief Financial Officer 3Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 3Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3
Cached News: